Epithelioid malignant mesothelioma is a rare and aggressive type of cancer that affects the tissue around the lungs, heart, and other organs. This type of cancer is caused by exposure to asbestos, a mineral found in some building materials. Although epithelioid malignant mesothelioma is a rare cancer, it is important to know the different treatment options available for patients.
Surgery is the most common treatment for epithelioid malignant mesothelioma. Depending on the stage of the cancer and the patient’s overall health, surgery may involve removing part or all of the affected organ. In some cases, a portion of the surrounding tissue may also be removed. The goal of surgery is to remove as much of the cancerous tissue as possible.
Radiation therapy is another treatment option for epithelioid malignant mesothelioma. This type of therapy uses high-energy beams to kill cancer cells. Radiation therapy may be used alone or in combination with other treatments.
Chemotherapy may be used in the treatment of epithelioid malignant mesothelioma. This type of therapy uses drugs to kill cancer cells. Chemotherapy may be used alone or in combination with other treatments.
Immunotherapy is a newer type of treatment that is being studied for use in epithelioid malignant mesothelioma. This type of therapy uses the body’s own immune system to fight the cancer. Immunotherapy is still being studied and is not widely available.
Clinical trials are also an option for epithelioid malignant mesothelioma patients. Clinical trials are research studies that test new treatments. Participation in a clinical trial may offer access to treatments that are not yet widely available.
In addition to these treatments, supportive care may be important for epithelioid malignant mesothelioma patients. Supportive care includes pain management, nutrition, and emotional support.
Overall, there are many treatment options available for epithelioid malignant mesothelioma patients. It is important to talk to your doctor to find out which treatment is right for you.